(d) The Equity Cure shall be deemed to have been received on the Reference Date falling on last day of the Reference Period and shall be included in the calculation of the Leverage Ratio Maintenance Test until such time as that Reference Date falls outside the Reference Period.
(f) For the avoidance of doubt, Net Interest Bearing Debt shall not be reduced by any amount of the Equity Cure.
18
13. SPECIAL UNDERTAKINGS
So long as any Bond remains outstanding, the Issuer undertakes to comply with the special undertakings set forth in this Clause 13.
13.1 Distributions
(a) The Issuer shall not, and shall procure that none of the Subsidiaries will (i) pay any dividend on shares, (ii) repurchase any of its own shares, (iii) redeem its share capital or other restricted equity with repayment to shareholders, (iv) repay principal or pay interest under any shareholder loans or (v) make any other similar distributions or transfers of value (Sw. värdeöverföringar) to the Issuer's, or the Subsidiaries', direct and indirect shareholders or the Affiliates of such direct and indirect shareholders. Sub paragraphs (i) to (v) above are together and individually referred to as a "Restricted Payment":
(b) Notwithstanding paragraph (a) above, a Restricted Payment may be made by:
(i) subject to sub-paragraph (ii) below, the Issuer to its shareholders, if the Incurrence Test (including the Restricted Payment on a pro rata basis) is met and the aggregate amount o f all Restricted Payments made by the Issuer to its shareholders in a financial year (including the Restricted Payment in question) does not exceed:
